Início do conteúdo
Interim recommendations for use of the AZD1222
Interim recommendations for use of the AZD1222
Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID19 developed by Oxford University and AstraZeneca
Voltar ao topoVoltar